PETNET allies with academia
CTI Molecular Imaging subsidiary PETNET Solutions is partnering with Johns Hopkins Healthcare to manage production and distribution of clinical PET radiopharmaceuticals produced at the existing Hopkins PET cyclotron production facility. The agreement
CTI Molecular Imaging subsidiary PETNET Solutions is partnering with Johns Hopkins Healthcare to manage production and distribution of clinical PET radiopharmaceuticals produced at the existing Hopkins PET cyclotron production facility. The agreement calls for PETNET to manage the production facility and supply PET isotopes to the surrounding market, as well as help support some of Hopkins' PET clinical and research programs.
PETNET has also agreed to collaborate with the Yerkes National Primate Research Center of Emory University in the research and development of new PET molecular probes. The two will operate a preclinical research site at Yerkes' new neuroscience building, scheduled to open this fall. PETNET also plans to establish a production facility at Yerkes to supply PET isotopes for clinical and research needs, including those at the center.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
